APLS

News Biogen Lands Two Fast-Growing Drugs In Blockbuster Apellis Deal

14d ago

News Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy

14d ago

News Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday

14d ago

News 1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst

14d ago

News What Analysts Are Saying About Apellis Pharmaceuticals Stock

14d ago

News Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study

14d ago

News Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data

14d ago

News Expert Outlook: Apellis Pharmaceuticals Through The Eyes Of 15 Analysts

14d ago

News This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story

14d ago

SEC filing APLS Merges with Biogen, $41 Cash per Share + $4 CVR, $93.9M Notes Outstanding, Delists Nasdaq

19d ago

SEC filing APLS Amends Exec Separation Plan, Accelerates Equity Upon Change Control, Expands Good Reason Exclusion for C-Level Officers

29d ago

News Biogen raised to Overweight at Piper Sandler on Apellis buyout

48d ago

News Biogen Taps Alloy Platform To Push Antisense Drug Pipeline Forward

56d ago

News Apellis Pharmaceuticals reports Q4 results

98d ago

News Apellis Pharmaceuticals Q4 2025 Earnings Preview

98d ago

Insider trade Sale by Mark Jeffrey Delong (Chief Business & Strat Officer)

104d ago

Insider trade Sale by David O. Watson

104d ago

Insider trade Sale by Pascal Deschatelets

104d ago

Insider trade Sale by Nur Nicholson

104d ago

Insider trade Sale by Cedric Francois

104d ago

Insider trade Sale by Mark Jeffrey Delong

104d ago

Insider trade Sale by Timothy Eugene Sullivan

104d ago

Insider trade Sale by David O. Watson

104d ago

Insider trade Sale by Mark Jeffrey Delong

104d ago

Insider trade Sale by James George Chopas

104d ago